Immune checkpoint inhibitors (ICIs) have reshaped cancer therapy. ICIs enhance T cell
activation through various mechanisms and may help reverse the exhausted phenotype of …

Acute kidney injury (AKI) occurs commonly in patients with advanced cirrhosis and
negatively impacts pre-and post-transplant outcomes. Physiologic changes that occur in …

We assessed the risk of chronic kidney disease (CKD) in chronic hepatitis C virus (HCV)‐
infected patients and the incidence reduction of CKD after receipt of HCV treatment. We also …

Extracorporeal “blood purification,” mainly in the form of hemodialysis has been a major
portion of the clinical activity of many nephrologists for the past 5 decades. A possibly older …

Objectives Chronic hepatitis C virus (HCV) infection represents a leading worldwide medical
and social problem. The expanding knowledge of HCV lifecycle has led to the development …

Hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) is
associated with more rapid liver disease progression and reduced renal graft and patients' …

Background Hepatitis C virus (HCV)‐associated mixed cryoglobulinaemia is the
manifestation of an inflammation of small and medium‐sized vessels produced by a …

Inflammatory liver diseases, including nonalcoholic steatohepatitis (NASH), alcohol-
associated liver disease (ALD), hepatitis C virus (HCV), and ALD/HCV, account for nearly 2 …

The association of chronic hepatitis C with immune related syndromes has been frequently
reported. There is a great range of clinical manifestations affecting various systems and …

Background The epidemiology and risk factors for hepatitis C virus (HCV) infection in
Rwanda are not well known; however, this information is crucial to shaping the country's …